The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells. J. Can. Res. Updates. 2014;3(2): 108-116. doi:10.6000/1929-2279.2014.03.02.5